AFFINIA THERAPEUTICS INC.

AFFINIA THERAPEUTICS

Gene therapy products, namely biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue, for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system; biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system;THERAPEUTICS;

ARROWGENE THERAPEUTICS

Gene therapy products; pharmaceutical preparations, namely, gene therapy systems, gene therapy vectors, adeno-associated virus (AAV) vectors, and vectors; biological preparations for medical use in medical and clinical gene therapy;Testing, inspection, research, and development of pharmaceutical preparations, namely, vectors and preparations for gene therapy; engineering services to develop vectors and gene therapy products;

CART

Gene therapy products; biopharmaceutical preparations; biological preparations; therapeutic products for medical and clinical gene therapy; all of the above for the treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system;Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system;

MART

Gene therapy products; biopharmaceutical preparations; biological preparations; therapeutic products for medical and clinical gene therapy; all of the above for the treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system;Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system;

PART

Gene therapy products; biopharmaceutical preparations; biological preparations; therapeutic products for medical and clinical gene therapy; all of the above for the treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system;Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system;